Neumora Therapeutics, Inc.
NMRA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001885522
In the last 90 days, Neumora Therapeutics, Inc. insiders filed 0 open-market purchases and 2 sales; 113 institutions reported holding it in 13F filings for Q2 2026, worth $129.2M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Neumora Therapeutics, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 38
- +38 vs. Q2 2023
- Shares held
- 36.4M
- +36.4M vs. Q2 2023
- Total value
- $512.0M
- +$512.0M vs. Q2 2023
- New holders
- 38
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NMRA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 113 | $129.2M |
| Q1 2026 | 114 | $137.2M |
| Q4 2025 | 102 | $112.7M |
| Q3 2025 | 93 | $92.2M |
| Q2 2025 | 98 | $41.1M |
| Q1 2025 | 116 | $65.2M |
| Q4 2024 | 135 | $851.6M |
| Q3 2024 | 104 | $907.0M |
| Q2 2024 | 93 | $627.4M |
| Q1 2024 | 88 | $725.4M |
| Q4 2023 | 60 | $744.8M |
| Q3 2023 | 38 | $512.0M |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Neumora Therapeutics, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Softbank Group Corp | 7,646,916 | $107.9M | 1.19% | +7,646,916 | New |
| FMR LLC | 5,624,353 | $79.4M | 0.01% | +5,624,353 | New |
| MIC Capital Management UK LLP | 4,460,700 | $62.9M | 14.35% | +4,460,700 | New |
| WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST | 3,309,124 | $46.7M | 0.62% | +3,309,124 | New |
| Artal Group S.A. | 2,802,702 | $39.5M | 1.72% | +2,802,702 | New |
| Citadel Advisors LLC | 2,168,518 | $29.7M | 0.03% | +2,168,518 | New |
| EcoR1 Capital, LLC | 2,071,450 | $29.2M | 1.00% | +2,071,450 | New |
| Avidity Partners Management LP | 1,800,000 | $25.4M | 1.02% | +1,800,000 | New |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 1,699,313 | $24.0M | 0.54% | +1,699,313 | New |
| OrbiMed Advisors LLC | 1,500,000 | $21.2M | 0.49% | +1,500,000 | New |
| Johnson & Johnson | 912,128 | $12.9M | 4.74% | +912,128 | New |
| Soros Capital Management LLC | 588,235 | $8.30M | 4.16% | +588,235 | New |
| Millennium Management LLC | 274,748 | $3.88M | 0.00% | +274,748 | New |
| Marshall Wace, LLP | 256,412 | $3.62M | 0.01% | +256,412 | New |
| Alphabet Inc. | 199,608 | $2.82M | 0.18% | +199,608 | New |
| Scoggin Management LP | 150,000 | $2.12M | 2.86% | +150,000 | New |
| Ensign Peak Advisors, Inc | 150,000 | $2.12M | 0.00% | +150,000 | New |
| Geode Capital Management, LLC | 122,186 | $1.72M | 0.00% | +122,186 | New |
| Cormorant Asset Management, LP | 92,293 | $1.30M | 0.08% | +92,293 | New |
| Goldman Sachs Group Inc | 73,600 | $1.04M | 0.00% | +73,600 | New |
| Two Sigma Investments, LP | 58,500 | $825.4K | 0.00% | +58,500 | New |
| Vanguard Group Inc | 50,000 | $705.5K | 0.00% | +50,000 | New |
| Norges Bank | 50,000 | $705.5K | 0.00% | +50,000 | New |
| Greenland Capital Management LP | 47,613 | $671.8K | 0.08% | +47,613 | New |
| Point72 Middle East FZE | 43,713 | $616.8K | 0.04% | +43,713 | New |
| Susquehanna International Group, LLP | 28,834 | $406.8K | 0.00% | +28,834 | New |
| First Trust Advisors LP | 26,770 | $377.7K | 0.00% | +26,770 | New |
| BlackRock Inc. | 25,000 | $352.7K | 0.00% | +25,000 | New |
| Laurion Capital Management LP | 21,557 | $304.2K | 0.01% | +21,557 | New |
| Qube Research & Technologies Ltd | 21,400 | $302.0K | 0.00% | +21,400 | New |
| Royal Bank of Canada | 20,078 | $283.0K | 0.00% | +20,078 | New |
| Citigroup Inc | 14,416 | $203.4K | 0.00% | +14,416 | New |
| Zimmer Partners, LP | 12,500 | $176.4K | 0.00% | +12,500 | New |
| Soros Fund Management LLCSuperinvestorSoros Fund Management | 10,000 | $141.1K | 0.00% | +10,000 | New |
| Ghisallo Capital Management LLC | 10,000 | $141.1K | 0.01% | +10,000 | New |
| Legal & General Group Plc | 10,000 | $140.3K | 0.00% | +10,000 | New |
| Morgan Stanley | 400 | $5.64K | 0.00% | +400 | New |
| Salem Investment Counselors Inc | 100 | $1.41K | 0.00% | +100 | New |